HatefMassoumiMD
Gastroenterology • New York, NYHepatology & Liver Transplantation
Clinical Director of Hepatology Lenox Hill Hospital Northwell Center for Liver Disease and Transplantation
Dr. Massoumi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
261 E 78th St
New York, NY 10075Phone+1 646-374-0401Fax+1 212-988-1071
Summary
- Dr. Hatef Massoumi is a Hepatologist/Gastroenterologist based in New York, NY, with subspecialties in hepatology and liver transplantation. He completed his gastroenterology fellowship at New York Medical College/Our Lady of Mercy Medical Center and a transplant hepatology fellowship at the Icahn School of Medicine at Mount Sinai. His clinical expertise includes transplant hepatology, metabolic and immune mediated liver diseases, and liver cancer. Dr. Massoumi has multiple publications, including studies on pre-transplant immune checkpoint inhibitors in HCC, and treatment of viral and immune mediated hepatitis and the impact of granulocyte colony-stimulating factor in alcoholic hepatitis. His work also addresses the effects of SARS-CoV-2 vaccination and immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Transplant Hepatology, 2006 - 2007
New York Medical College at St Vincent's Hospital and Medical Center of New YorkFellowship, Gastroenterology, 2003 - 2006
Montefiore Medical Center/Albert Einstein College of Medicine (Wakefield Campus)Residency, Internal Medicine, 1998 - 2001
Iran University of Medical SciencesClass of 1994
Certifications & Licensure
NY State Medical License 2001 - 2025
Publications & Presentations
PubMed
- 10 citationsImpact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.Mohammad Saeid Rezaee-Zavareh, Yee Hui Yeo, Tielong Wang, Zhiyong Guo, Parissa Tabrizian
Journal of Hepatology. 2025-01-01 - 1 citationsSuperior Mesenteric Vein Stenting to Manage Persistent Chylothorax.Tate Kirk, Matthew Sagnelli, Gendel Vyacheslav, Mark Westcott, Matthew Inra
Cardiovascular and Interventional Radiology. 2024-09-01 - Granulocyte colony-stimulating factor does not improve mortality in severe alcoholic hepatitis: a single-center experience from the United States.Jonathan Nahas, Clara Y Tow, Kristina R Chacko, Tehseen Haider, Hatef Massoumi
Gastroenterology and Hepatology from Bed to Bench. 2023-01-01
Press Mentions
Managing Primary Biliary Cholangitis Progression and SymptomsNovember 15th, 2024- Primary Biliary Cholangitis Incidence and Prevalence GrowingNovember 15th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
